Abstract: Plasmodesmal resident components are identified, characterized and isolated. Compositions comprising these components are described and methods of use thereof for plasmodesmal flux modulation and targeting are enabled. In a first embodiment, a novel plasmodesmal receptor-like protein, referred to herein as pldp1, reveals signals sufficient for targeting to plasmodesmata via the secretory pathway. In the second embodiment a novel plasmodesmal protein that is anchor into the external face of the plasma membrane and binds to callose is provided.

Abstract: A method of degrading an organic nitrogen compound to its reduction products, in which the compound is caused to react with a reducing agent in the presence of a complex of a corrin containing a metal-centered ring system. Preferred complexes are cobalt-centered hydrolysis products of Vitamin B12, such as cobyrinic acid, and in one embodiment these complexes are immobilised on a substrate. Using the method environmental pollutants such as nitrobenzenes may be rapidly reduced.

Abstract: A method for dehalogenation of organohalogen compounds, e.g. environmental pollutants in industrial waste. The organohalogen is reacted with a reducing agent in the presence of a selected metal-centered corrin, porphyrin or phthalocyanine complex. Preferred complexes are hydrolysis products of cyanocobalamin, of formula (I), in which R.sup.1 is NH.sub.2 or OH, R.sup.2 is H, CH.sub.2 CH.sub.2 COOH or CH.sub.2 CH.sub.2 CONH.sub.2, R.sup.3 is H, CH.sub.2 CH.sub.2 COOH or CH.sub.2 CH.sub.2 CONH.sub.2, and R.sup.4 is NHCH.sub.2 CH(OH)CH.sub.3, OH or NH.sub.2. The complex is preferably immobilized on a substrate. Some novel metal-centered porphyrin complexes are also described. A dehalogenation apparatus using the method of the invention is also described.